You are here: Home » Companies » News
Business Standard

Dr Reddy's launches Plaquenil's generic version in US after USFDA clearance

The tablets are available in 200 mg in the bottle count sizes of 100 and 500

Press Trust of India  |  New Delhi 

medicine, drug, antibiotic, doctor, pharmaceuticals
Representative Image

Dr Reddy's Laboratories on Wednesday announced the launch of generic version of Plaquenil, used to treat malaria, lupus erythematosus, and rheumatoid arthritis, in the US.

The launch follows approval of Hydroxychloroquine Sulfate tablets, a therapeutic equivalent generic version of Plaquenil, by the US Food and Drug Administration (USFDA), Dr Reddy's Laboratories said in a filing.

Quoting IMS Health data, Dr Reddy's Laboratories, the brand and generic had US sales of approximately $215 million for the most recent twelve months ending in May 2018.

Dr Reddy's said its product Hydroxychloroquine Sulfate tablets are available in 200 mg tablets in the bottle count sizes of 100 and 500.

is a trademark of

Shares of Dr Reddy's Laboratories were trading at Rs 2,293.95 apiece, down 1.11 per cent from the previous close on the

First Published: Wed, July 11 2018. 13:05 IST